Investors Press Releases Cardiol Therapeutics Appoints Thomas Moffatt as Chief Commercial Officer March 06, 2019 Cardiol Therapeutics Inc. Closes Over-Allotment January 18, 2019 Cardiol Therapeutics Completes Initial Public Offering and the Company’s Common Shares and Warrants Commence Trading on the Toronto Stock Exchange Under the Symbols “CRDL” and “CRDL.WT” December 20, 2018 Cardiol Therapeutics Appoints Mr. Chris Waddick as Chief Financial Officer, Ms. Anne Tomalin as Director of Regulatory Affairs, and Ms. Dolly Kao as Intellectual Property Counsel August 30, 2018 Cardiol Therapeutics Appoints Dr. Eldon Smith as Chairman and Dr. Guillermo Torre-Amione, Ms. Deborah Brown, and Mr. Iain Chalmers to its Board of Directors August 21, 2018 Cardiol Therapeutics Closes $10.5 Million Private Placement May 24, 2018 Cardiol Therapeutics Appoints Dr. James Young as Chair of the Company’s Scientific Advisory Board May 08, 2018 Cardiol Therapeutics to Present at the 2018 BIO CEO & Investor Conference in NYC February 06, 2018 Cardiol Therapeutics Demonstrates Novel Way to Target Drugs for Treating Heart Failure Using Nanotechnology January 09, 2018 Cardiol Therapeutics to Present at the 2018 Biotech Showcase in San Francisco January 03, 2018 Page 2 of 3«123»
